Olympus (OTCMKTS:OCPNY) Share Price Crosses Below 200 Day Moving Average – Should You Sell?

Olympus Co. (OTCMKTS:OCPNY)’s share price passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $18.00 and traded as low as $18.00. Olympus shares last traded at $18.00, with a volume of 400 shares changing hands.

Analyst Ratings Changes

Separately, Jefferies Financial Group upgraded Olympus to a “buy” rating in a research note on Monday, May 18th. One analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the company has a consensus rating of “Buy”.

Olympus Trading Down 1.4%

The company has a quick ratio of 1.48, a current ratio of 1.99 and a debt-to-equity ratio of 0.59. The firm has a 50 day moving average of $18.00 and a 200 day moving average of $18.00. The firm has a market cap of $23.15 billion, a PE ratio of 21.95, a P/E/G ratio of 1.07 and a beta of 0.70.

About Olympus

Olympus Corporation is a Tokyo-headquartered manufacturer specializing in medical and scientific imaging, precision optics and related equipment. The company’s medical systems business is focused on endoscopic technologies and therapeutic devices used in minimally invasive diagnosis and treatment, supplying hospitals and clinical facilities with endoscopes, visualization platforms and accessories. In addition to healthcare, Olympus serves scientific and industrial customers with microscopes, imaging systems, non-destructive testing equipment and precision measurement tools used in research, manufacturing and quality control.

In recent years the company completed a strategic refocus on healthcare and scientific solutions, divesting its consumer camera business in 2020 to concentrate resources on medical device development, services and life-science applications.